HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.

about

Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.Towards conformational fidelity of a quaternary HIV-1 epitope: computational design and directed evolution of a minimal V1V2 antigen.

P2860

Q50043326-14CDC5A9-5A49-47FA-9449-101D7A7CE71D Q55518743-314F4734-9457-4738-A192-9A1E2684BB8E

P2860

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.

Item

http://www.wikidata.org/entity/Q47547483

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

HIV-1 Envelope Glycoproteins f ...... nd Durability among Vaccinees.

@en

HIV-1 Envelope Glycoproteins f ...... nd Durability among Vaccinees.

@nl

type

Item

label

HIV-1 Envelope Glycoproteins f ...... nd Durability among Vaccinees.

@en

HIV-1 Envelope Glycoproteins f ...... nd Durability among Vaccinees.

@nl

prefLabel

HIV-1 Envelope Glycoproteins f ...... nd Durability among Vaccinees.

@en

HIV-1 Envelope Glycoproteins f ...... nd Durability among Vaccinees.

@nl

P1476

HIV-1 Envelope Glycoproteins f ...... nd Durability among Vaccinees.

@en

P2093

Abraham Pinter

http://www.w3.org/2001/XMLSchema#string

Allan C deCamp

http://www.w3.org/2001/XMLSchema#string

Bette T Korber

http://www.w3.org/2001/XMLSchema#string

Carmela Irene

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

Hua-Xin Liao

http://www.w3.org/2001/XMLSchema#string

James Peacock

http://www.w3.org/2001/XMLSchema#string

Linda J Harris

http://www.w3.org/2001/XMLSchema#string

Nicole L Yates

http://www.w3.org/2001/XMLSchema#string

Phillip W Berman

http://www.w3.org/2001/XMLSchema#string

P2860

Approaches to preventative and therapeutic HIV vaccines

HIV-Host Interactions: Implications for Vaccine Design

Immune correlates of vaccine protection against HIV-1 acquisition

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses

Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.

P31

scholarly article

P356

10.1128/JVI.01843-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29386288

http://www.w3.org/2001/XMLSchema#string

P932

5874409

http://www.w3.org/2001/XMLSchema#string

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.

about

P2860

P2860

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932